Prolactin (PRL), secreted predominantly by the pituitary, and placental derived human placental lactogen (hPL) promote maternal pancreatic beta cell expansion and/or insulin secretion to control increased maternal glucose levels due to increased insulin resistance, thereby protecting against hyperglycaemia and the development of GDM [53]. The gene discussed is INS; the disease is Hyperglycemia.